MSI2 and chronic myelogenous leukemia, BCR-ABL1 positive: In the human context, aberrantly high expression of MSI2 correlates with more aggressive CML disease states and is associated with poor prognosis in acute myeloid leukemia and MDS (Ito et al., 2010, Kharas et al., 2010, Taggart et al., 2016).